China Pharmaceutical Contract Packaging Market Size, Share & Forecast 2023-2028

China Pharmaceutical Contract Packaging Market Overview 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “China pharmaceutical contract packaging market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the China pharmaceutical contract packaging market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The China pharmaceutical contract packaging market size reached US$ 3.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.8% during 2023-2028.

Pharmaceutical contract packaging is the practice where pharmaceutical companies delegate their packaging needs to external service providers. This process harnesses cutting-edge technology and specialized knowledge to manage the packaging of various pharmaceutical items, including medicines, medical devices, and healthcare products. It entails the expert packaging of pharmaceutical goods by third-party firms, enabling pharmaceutical manufacturers to concentrate on their primary strengths while ensuring effective and compliant packaging solutions. As it plays a crucial role in guaranteeing the secure, precise, and dependable packaging of pharmaceutical products in accordance with regulatory requirements, there is a growing demand for pharmaceutical contract packaging in China.

China Pharmaceutical Contract Packaging Market Trends and Drivers:

Currently, China’s market growth is being bolstered by several key factors. Firstly, there’s a rising demand for packaging solutions that are both efficient and cost-effective. Secondly, the country’s market is benefiting from an increased desire for personalized and innovative packaging solutions, aimed at enhancing customer satisfaction. Additionally, the adoption of pharmaceutical contract packaging is on the upswing due to its ability to streamline operations, cut production costs, and ensure compliance with complex packaging regulations, all of which are driving market growth in China. Furthermore, the incorporation of features like tamper-evident seals, child-resistant packaging, and patient-friendly packaging formats is exerting a positive influence on the market. Lastly, the growing popularity of advanced technologies such as smart packaging and serialization, which enhance product security, is contributing to the market’s growth in China.

The report segmented the market on the basis of region, industry, type and packaging.

Breakup by Industry:

  • Small Molecule
  • Biopharmaceutical
  • Vaccine

Breakup by Type:

  • Sterile
  • Non-Sterile

Breakup by Packaging:

  • Plastic Bottles
  • Caps and Closures
  • Blister Packs
  • Prefilled Syringes
  • Parenteral Vials and Ampoules
  • Others

Breakup by Region:

  • Guangdong
  • Jiangsu
  • Shandong
  • Zhejiang
  • Henan
  • Others

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *